[ Tue, Jan 16th 2024 ]: WOPRAI
[ Tue, Jan 16th 2024 ]: WOPRAI
[ Tue, Jan 16th 2024 ]: WOPRAI
[ Tue, Jan 16th 2024 ]: WOPRAI
[ Tue, Jan 16th 2024 ]: WOPRAI
[ Tue, Jan 16th 2024 ]: WOPRAI
[ Tue, Jan 16th 2024 ]: WOPRAI
[ Tue, Jan 16th 2024 ]: WOPRAI
[ Tue, Jan 16th 2024 ]: WOPRAI
[ Tue, Jan 16th 2024 ]: WOPRAI
[ Tue, Jan 16th 2024 ]: WOPRAI
[ Tue, Jan 16th 2024 ]: WOPRAI
[ Tue, Jan 16th 2024 ]: WOPRAI
[ Tue, Jan 16th 2024 ]: WOPRAI
[ Tue, Jan 16th 2024 ]: WOPRAI
[ Tue, Jan 16th 2024 ]: WOPRAI
[ Tue, Jan 16th 2024 ]: WOPRAI
[ Tue, Jan 16th 2024 ]: WOPRAI
[ Tue, Jan 16th 2024 ]: WOPRAI
[ Tue, Jan 16th 2024 ]: WOPRAI
[ Tue, Jan 16th 2024 ]: WOPRAI
[ Tue, Jan 16th 2024 ]: WOPRAI
[ Tue, Jan 16th 2024 ]: WOPRAI
[ Tue, Jan 16th 2024 ]: WOPRAI
[ Tue, Jan 16th 2024 ]: WOPRAI
[ Tue, Jan 16th 2024 ]: WOPRAI
[ Tue, Jan 16th 2024 ]: WOPRAI
[ Tue, Jan 16th 2024 ]: WOPRAI
[ Tue, Jan 16th 2024 ]: WOPRAI
[ Tue, Jan 16th 2024 ]: WOPRAI
[ Tue, Jan 16th 2024 ]: WOPRAI
[ Tue, Jan 16th 2024 ]: WOPRAI
[ Tue, Jan 16th 2024 ]: WOPRAI
[ Tue, Jan 16th 2024 ]: WOPRAI
[ Tue, Jan 16th 2024 ]: WOPRAI
[ Tue, Jan 16th 2024 ]: WOPRAI
[ Tue, Jan 16th 2024 ]: WOPRAI
[ Tue, Jan 16th 2024 ]: WOPRAI
[ Tue, Jan 16th 2024 ]: WOPRAI
[ Tue, Jan 16th 2024 ]: WOPRAI
[ Tue, Jan 16th 2024 ]: WOPRAI
[ Tue, Jan 16th 2024 ]: WOPRAI
[ Tue, Jan 16th 2024 ]: WOPRAI
[ Tue, Jan 16th 2024 ]: WOPRAI
[ Tue, Jan 16th 2024 ]: WOPRAI
[ Tue, Jan 16th 2024 ]: WOPRAI
[ Tue, Jan 16th 2024 ]: WOPRAI
[ Tue, Jan 16th 2024 ]: WOPRAI
Daniel Ives Maintained (XOS) at Buy with Increased Target to $13 on, Jan 16th, 2024
- 🞛 This publication is a summary or evaluation of another publication
Daniel Ives of Wedbush, Maintained "Xos, Inc." (XOS) at Buy with Increased Target from $4 to $13 on, Jan 16th, 2024.
Daniel has made no other calls on XOS in the last 4 months.
There are 2 other peers that have a rating on XOS. Out of the 2 peers that are also analyzing XOS, 1 agrees with Daniel's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Michael Ward of "Benchmark" Downgraded from Strong Buy to Hold and Decreased Target to $30 on, Monday, November 13th, 2023
This is the rating of the analyst that currently disagrees with Daniel
- Donovan Schafer of "Northland Capital Markets" Upgraded from Hold to Buy and Held Target at $23 on, Friday, November 10th, 2023